Cite
For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures.
MLA
Zhou, Qiong, et al. “For or against Adjuvant Trastuzumab for PT1a-BN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures.” PLoS ONE, vol. 9, no. 1, Jan. 2014, pp. 1–7. EBSCOhost, https://doi.org/10.1371/journal.pone.0083646.
APA
Zhou, Q., Yin, W., Du, Y., & Lu, J. (2014). For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures. PLoS ONE, 9(1), 1–7. https://doi.org/10.1371/journal.pone.0083646
Chicago
Zhou, Qiong, Wenjin Yin, Yueyao Du, and Jinsong Lu. 2014. “For or against Adjuvant Trastuzumab for PT1a-BN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures.” PLoS ONE 9 (1): 1–7. doi:10.1371/journal.pone.0083646.